B-type natriuretic peptide levels are decreased by reducing dietary salt intake in patients with compensated heart failure with preserved ejection fraction

Internal Medicine Journal

Volumn 43, Issue 6, 2013, Pages 663-667

  Sadanaga, T ^a,b   Ando, K ^c   Hirota, S ^a   Mitamura, H ^d   Tsuchihashi, T ^f   Kohsaka, S ^b   Fukuda, K ^b   Ogawa, S ^e  

^a Ueki Hospital   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d SAISEIKAI CENTRAL HOSPITAL   (Japan)

^e International University of Health and Welfare Mita Hospital   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

Author keywords

Heart failure; Natriuretic peptide; Outpatient; Salt; Spot urine

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SODIUM; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; BODY WEIGHT; CREATININE URINE LEVEL; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SALT INTAKE; SODIUM EXCRETION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; SODIUM CHLORIDE, DIETARY; STROKE VOLUME;

EID: 84879023933     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12063     Document Type: Article

References (14)

1. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG etal. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977-2016.
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P, Poole-Wilson PA etal. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure. 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442.
3. Volpe M, Tritto C, DeLuca N, Rubattu S, Rao MA, Lamenza F etal. Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure. Circulation 1993; 88: 1620-1627.
4. He J, Ogden L, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Dietary sodium intake and incidence of congestive heart failure in overweight US men and women. First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Arch Intern Med 2002; 162: 1619-1624.
5. Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P. Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? Clin Sci (Lond) 2008; 114: 221-230.
6. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P etal. Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
7. Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E etal. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 2007; 49: 1733-1739.
8. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K etal. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
9. Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H etal. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens 2002; 16: 97-103.
10. Kawano Y, Tsuchihashi T, Matsuura H, Ando K, Fujita T, Ueshima H, Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension. Report of the working group for dietary salt reduction of the Japanese Society of Hypertension: (2) assessment of salt intake in the management of hypertension. Hypertens Res 2007; 10: 887-893.
11. Damgaard M, Goetze JP, Norsk P, Gadsboll N. Altered sodium intake affects plasma concentrations of BNP but not proBNP in healthy individuals and patients with compensated heart failure. Eur Heart J 2007; 28: 2726-2731.
12. Damgaard M, Norsk P, Gustafsson F, Kanters JK, Christensen NJ, Bie P etal. Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 2006; 290: R1294-1301.
13. Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR etal. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke. A call to action from the American Heart Association. Circulation 2011; 123: 1138-1143.
14. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M etal. Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.